Rasalect 1 mg is a notable example of contemporary pharmacology, designed to provide relief and management for individuals with Parkinson’s disease.
Features
Each tablet of Rasalect 1 mg contains Rasagiline Mesylate as its active ingredient. Rasagiline is a selective and irreversible inhibitor of monoamine oxidase-B (MAO-B), an enzyme that breaks down dopamine in the brain. By inhibiting MAO-B, Rasalect helps maintain higher levels of dopamine, a neurotransmitter that plays a crucial role in controlling movement and coordination.
Products
Rasalect 1 mg aids in the management of Parkinson’s disease by assisting in the regulation of dopamine levels in the brain. By preserving dopamine, Rasalect contributes to improved motor functions and reduces the symptoms associated with the disease, such as tremors, rigidity, and bradykinesia (slowness of movement).
Usage
Rasalect tablets are meant for oral administration and should be taken as directed by a healthcare professional. Dosage and administration instructions may vary based on an individual’s medical condition and the doctor’s recommendations. Patients are advised to read the label and follow the prescribed dosage for optimal results. It is important to consult a healthcare provider for detailed instructions and any potential interactions with other medications.
In summary, Rasalect 1 mg presents an effective approach to managing Parkinson’s disease symptoms. Through its active ingredient Rasagiline Mesylate, Rasalect helps maintain dopamine levels, leading to improved motor control and alleviation of movement-related issues.
Manufacturer
Rasalect 1 mg is manufactured by Sun Pharmaceutical Industries Ltd, a reputable pharmaceutical company known for producing high-quality medications.
Reviews
There are no reviews yet.